Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17097
Country/Region: Malawi
Year: 2015
Main Partner: Project Concern International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $1,520,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $150,000
Care: TB/HIV (HVTB) $50,000
Strategic Information (HVSI) $50,000
Health Systems Strengthening (OHSS) $100,000
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $100,000
Testing: HIV Testing and Counseling (HVCT) $250,000
Sexual Prevention: Other Sexual Prevention (HVOP) $150,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $200,000
Treatment: Adult Treatment (HTXS) $420,000
Treatment: Pediatric Treatment (PDTX) $50,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 6,587
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 698
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 20,642
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 32
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 31
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 16
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 15
PMTCT_ARV Sum of New and Current disaggregates 2016 31
PMTCT_STAT Number of new ANC and L&D clients 2016 649
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 617
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 6,587
TX_CURR Age/Sex: <1 Female 2016 4
TX_CURR Age/Sex: <1 Male 2016 3
TX_CURR Age/Sex: 1-4 Female 2016 33
TX_CURR Age/Sex: 1-4 Male 2016 30
TX_CURR Age/Sex: 5-14 Female 2016 153
TX_CURR Age/Sex: 5-14 Male 2016 154
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 4,727
TX_CURR Sum of age/sex disaggregates 2016 4,727
TX_NEW Breastfeeding status 2016 39
TX_NEW By Age/Sex: <1 Female 2016 17
TX_NEW By Age/Sex: <1 Male 2016 15
TX_NEW By Age/Sex: 1-4 Female 2016 32
TX_NEW By Age/Sex: 1-4 Male 2016 36
TX_NEW By Age/Sex: 10-14 Female 2016 26
TX_NEW By Age/Sex: 10-14 Male 2016 22
TX_NEW By Age/Sex: 15-19 Female 2016 12
TX_NEW By Age/Sex: 15-19 Male 2016 3
TX_NEW By Age/Sex: 20-24 Female 2016 47
TX_NEW By Age/Sex: 20-24 Male 2016 6
TX_NEW By Age/Sex: 25-49 Female 2016 218
TX_NEW By Age/Sex: 25-49 Male 2016 127
TX_NEW By Age/Sex: 5-9 Female 2016 25
TX_NEW By Age/Sex: 5-9 Male 2016 29
TX_NEW By Age/Sex: 50+ Female 2016 17
TX_NEW By Age/Sex: 50+ Male 2016 21
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 653
TX_NEW Pregnancy status 2016 142
TX_NEW Sum of Age/Sex disaggregates 2016 653
Cross Cutting Budget Categories and Known Amounts Total: $80,000
Condoms: Policy, Tools, and Services $50,000
Gender: Gender Based Violence (GBV) $30,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation